Literature DB >> 1420022

Randomized placebo controlled trial to assess the role of intracervical lignocaine in outpatient hysteroscopy.

J A Broadbent1, N C Hill, B G Molnár, K J Rolfe, A L Magos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1420022     DOI： 10.1111/j.1471-0528.1992.tb13886.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN： 0306-5456


× No keyword cloud information.
  7 in total

1.  Effect of Cervical Lidocaine Gel for Pain Relief in Pipelle Endometrial Sampling.

Authors:  Ibrahim Karaca; Omer Erkan Yapca; Mehmet Adiyeke; Emrah Toz; Suna Yildirim Karaca
Journal:  Eurasian J Med       Date:  2016-10

2.  Comparing Transcervical Intrauterine Lidocaine Instillation with Rectal Diclofenac for Pain Relief During Outpatient Hysteroscopy: A Randomized Controlled Trial.

Authors:  Sussan S Mohammadi; Mina Abdi; Ali Movafegh
Journal:  Oman Med J       Date:  2015-05

3.  Transcervical intrauterine levobupivacaine or lidocaine infusion for pain control during endometrial biopsy.

Authors:  Nermin Kosus; Aydın Kosus; Ruveyda I Demircioglu; Serap A Simavli; Aysel Derbent; Esra Aktepe Keskin; Nilgün O Turhan
Journal:  Pain Res Manag       Date:  2014-01-20       Impact factor: 3.037

Review 4.  Pain relief for outpatient hysteroscopy.

Authors:  Gaity Ahmad; Sushant Saluja; Helena O'Flynn; Alessandra Sorrentino; Daniel Leach; Andrew Watson
Journal:  Cochrane Database Syst Rev       Date:  2017-10-05

Review 5.  Local anaesthesia for pain control during outpatient hysteroscopy: systematic review and meta-analysis.

Authors:  Natalie A M Cooper; Khalid S Khan; T Justin Clark
Journal:  BMJ       Date:  2010-03-23

6.  Diagnostic hysteroscopy - a retrospective study of 1545 cases.

Authors:  Andreea Stefanescu; Bogdan Marinescu
Journal:  Maedica (Buchar)       Date:  2012-12

7.  Transcervical intrauterine levobupivacaine infusion or paracervical block for pain control during endometrial biopsy.

Authors:  Nermin Köşüş; Aydin Köşüş; Ayşe Güler; Serap A Simavli; Nilgün Ö Turhan
Journal:  Exp Ther Med       Date:  2012-01-30       Impact factor: 2.447
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.